May 28, 2020 8:30 am EDT Abeona Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
May 6, 2020 4:14 pm EDT Abeona Therapeutics Reports First Quarter Financial Results and Business Updates
Apr 21, 2020 4:04 pm EDT Abeona Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Apr 21, 2020 8:00 am EDT Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors
Mar 17, 2020 7:30 am EDT Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
Mar 16, 2020 4:20 pm EDT Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates
Feb 26, 2020 8:00 am EST Abeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Feb 12, 2020 2:15 pm EST Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™
Jan 21, 2020 8:00 am EST Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa
